Cyclerion Therapeutics, Inc. - CYCN

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q4 2025 · Q3 2025
Value (USD)
Total reported value ($000)
$370K
QoQ value delta ($000)
-$220K (-37.29%)
Implied price effect (QoQ)
-45.21%
Shares
Total shares
296,255
QoQ shares delta
+37,419 (+14.46%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (CYCN)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q4 2025)

Top 25 only Full list
Early Q2 2026 data: only 21 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
Siren, L.L.C. 146 115,603 0.0%
GEODE CAPITAL MANAGEMENT, LLC 55 43,302 0.0%
TWO SIGMA INVESTMENTS, LP 52 41,555 0.0%
TWO SIGMA ADVISERS, LP 35 28,300 0.0%
VANGUARD GROUP INC 29 23,490 0.0%
BlackRock, Inc. 21 16,797 0.0%
XTX Topco Ltd 12 10,027 0.0%
CITIGROUP INC 10 8,204 0.0%
FMR LLC 6 4,740 0.0%
Tower Research Capital LLC (TRC) 4 3,154 0.0%
BANK OF AMERICA CORP /DE/ 0 107 0.0%
MORGAN STANLEY 0 1 0.0%
GROUP ONE TRADING LLC 0 192 0.0%
MAI Capital Management 0 100 0.0%
BNP PARIBAS FINANCIAL MARKETS 0 5 0.0%
UBS Group AG 0 376 0.0%
OSAIC HOLDINGS, INC. 0 130 0.0%
Activest Wealth Management 0 100 0.0%
WHI TRUST Co LLC 0 72 0.0%